Coronavirus Treatment : Prospective Vaccines / Drugs

The newly wide-spread SARS-CoV-2 is prevailing across the globe. The outbreak caused by the coronavirus has upheaved lives and led to an impending economy crash. Revolting against this pandemic are our front end health line workers. Although till date no vaccine or drug has been developed which prevents the Covid-19 disease but several patients who were infected by the Coronavirus have been cured. This has fueled the healthcare officials and researchers in the major pharmaceutical and bio-medical industries to comb through the existing trove of medicines and find a vaccine for as the cure against the Coronavirus.



Favilavir (Favipiravir)

This anti-viral drug has been approved by The National Medical Products Administration of China as a treatment for Coronavirus. This was used for the treatment of Influenza. During the human trials it showed efficiency in the treatment of coronavirus.


Fusogenix DNA Vaccine

The Fusogenix drug delivery platform is used against the coronavirus infection. The Fusogenix drug delivery platform is a proteo-lipid vehicle and this delivers its genetic payload directly inside the organism cells. The DNA vaccine is being prepared by the Entos Pharmaceuticals. Protein epitopes are being derived from the SARS-Cov-2 virus. The company is trying to develop an optimized payload which encloses multiple protein epitopes to instigate an immune response in the Covid-19 patient.


ChAdOx1 nCoV-19

The Jenner institute is developing an Adeno virus vaccine vector. The weakened version of common cold virus is genetically altered by adding Spike Glycoproteins which are found o the surface of the coronavirus. The change has been made in the ChAdOx1 virus to make it compatible for the human host as it primarily infects the chimpanzees. The Astra Zeneca’s vaccine was found at the University of Oxford.



Covid -19 in its last stages causes an inflammation of myeloid cells and thus infiltrates and damages the tissues. This is also known as the Cytokine Storm. The Gimisilumab is a human monoclonal antibody which inhibits the granulocyte-macrophage colony stimulating factor (GM-CSF) as this leads to high levels of pro-inflammatory cytokine in serum of the person infected by the Coronavirus.


The biopharmaceutical company Roviant Sciences is working on clinical development of Gimisilumab for treating the Acute Respiratory Distress Syndrome which is associated with the SARS-Cov-2 virus infection.



This is a Human Monoclonal Antibody which targets the Interleukin-6 receptor (IL-6R) and reduces the elevated level of IL-6 in the body. Tiziana Life Sciences is developing this drug which binds to the Interleukin as it is responsible for chronic inflammation of lungs  (ARDS).



A New York based Bio-pharmaceutical Company Beyond spring Inc. has recently filed a provisional U.S patent for its BPI-002 drug which is said to be effective against the viral infections including Covid-19. The drug can be orally administered. BPI-002 when combined attenuated coronavirus vaccine elicits an Immune response by activating CD4 and CD8 receptors, thus stimulating the helper T cells and the cytotoxic cells.


 INO-4800 DNA Vaccine

Inovio Biotechnological Company has collaborated with the Germany based Richter-Helm BioLoics for the advancement of the INO-4800 DNA vaccine against the SARS-Cov-2 virus which causes Covid-19. Coalition for Epidemic Preparedness Innovations (CEPI) is providing the funds for this agreement. Recombinant subunit vaccine

Clover Biopharmaceuticals and Dynavax Technologies Corporation have started a research collaboration for developing a trimeric S protein based vaccine (COVID-19 S-Trimer) by utilizing Clover’s patented Trimer-Tag techonology and Dynavax’s CpG 1018 adjuvant.



BIXT Biotechnological Company has invited collaborations for the development of its BX-25 drug for treating Acute Respiratory Distress Syndrome (ARDS) in the Covid-19 patients. In the late stages of the infection the patient’s vital organs are filled with fluid as the blood lacks diffused oxygen. BIOXYTRAN INC’s drug is 5000 times smaller than the blood cells and thus capable of transporting oxygen throughout the body. The drug continuously circulates with the half-life of 9 hours until it is processed by the liver.


Remdesivir (GS-5734) is an anti-viral drug created by the American Biopharmaceutical company Gilead Sciences Inc. This prodrug of the parent Adenosine Analog is a broad spectrum small molecule. Both Remdesivir and the adenosine analog (GS-441524) when metabolized in the body turn into active Nucleoside Triphosphate (NTP) and have showed efficacy against the coronavirus.



Galidesivir (BCX4430) is an Adenosine analog broad spectrum anti-viral drug being developed by BioCryst Pharmaceuticals. It is a Nucleoside RNA polymerase which inhibits the process of replication in the virus.


BNT162 RNA Vaccine

Biopharmaceutical New Technologies (BioNTech) and Pfizer Inc. have developed BNT162 vaccine. This is a modified nucleoside (mRNA) vaccine against covid-19 which is capable of generating an antigen-antibody immune response. 


The industry giants are also trying combination of various existing drugs as potential therapies. Many pharmaceutical companies like Johnson & Johnson, Roche, AstraZenca, Sanofi and Moderna are sprinting for finding the cure.

Leave a comment

Your email address will not be published. Required fields are marked *

Recent Posts

Trade Secrets in M&A Negotiations: Transparency vs. Confidentiality

Understanding Intellectual Property Rights in the Billion-Dollar Video Games Industry

The Legal and Ethical Quandaries of Patenting Genetic Algorithms

Influence of Artificial Intelligence on Copyright and Design Enforcement

India: The New Frontier of SEP Enforcement?

How to protect your intellectual property during Mergers and Acquisitions? 

The Role of SEPs in Fostering Global Technology Interoperability: A Case Study of 5G Cellular Networks

EoU/Claim Chart Preparation: Strategies for Effective Use in Patent Litigation

Navigating the Complex Process of Declaring a Standard Essential Patent (SEP)

Freedom to Operate Search: Ensuring Innovation Doesn’t Infringe Existing Patents

Unpacking Landmark SEP Litigation: The IWNComm vs Sony Case

Should we depend on AI to predict essentiality of SEPs

How Effective Search Strategies Win Patent Infringement Battles

Is Market Coverage the Right Patent Valuation Indicator for SEP?

Unlocking the Power of SEPs: The Driving Force Behind Telecom Evolution

Is AI-Created Art Copyrightable?

Ethical and Legal Implications in Patenting Human Augmentation Technologies

Navigating the Patent Paradox: Balancing Innovation and Monopoly

Cosmetics and the Struggle to Obtain Patents on Natural Ingredients

A Complete Guide to Using SEP Dashboard for Strategic Advantage

Understanding the Role of the Patent Trial and Appeal Board (PTAB) in Intellectual Property Protection

Comparing Design Patent Terms Across the Globe: How Long They Last in Different Nations

Navigating Patent Eligibility in the Tech Age: Section 101 and Software Patents

Can I be sued for unintentional patent infringement?

What to do When a Giant Corporation Tries to Steal Your Intellectual Property

Navigating the Maze of Inventorship: Who Holds the Key to Your Patents?

Don’t Forget to Consider These Five Things Before Filing a Patent

Common Pitfalls to Avoid While Conducting Freedom to Operate (FTO) Searches

The Future of Patent Research Services: Emerging Trends and Innovations to Watch Out for

The Advantages of Electing a Unitary Patent for European Inventions

Navigating Third-Party Intellectual Property: Ensuring Freedom to Operate

What is SEP Pooling & patent consortia? How do they complement each other?

Standard Essential Patents: The Myths and Realities of Standard Implementation

Beyond Legal Considerations: Ethical Implications of Balancing SEPs and IP Rights

How to Avoid Standard Essential Patents (SEPs) Litigation?

Are All Standard Essential Patents (SEPs) Actually Essential?

What Role Does FRAND Play in Standard Essential Patent Licensing?

How does outsourcing patent prosecution Can Benefit Law Firms and Corporates?

How Patent Analytics Can Help You Maximize Your IP Strategy

Four reasons why business owners might not want to apply for a patent right away

How standard essential patents (SEPs) are used to protect innovation and competition in the tech industry?

Why You Should Keep Track of Intellectual Property Metadata?

How Using a Negative Claim Restriction Can Be a Positive Patent Strategy?

Where Can I Identify Relevant Patents Using Non-Patent Literature?

What is the Punishment for Patent Infringement?

Can You Steal an Abandoned Patent?

What Happens When A Patent Is Invalidated?

How to Avoid Intellectual Property Infringement?

5 Best Practices for Patent Portfolio Management

How to Invalidate a Patent in 10 Easy Steps

How to Monetize Your IP?

How to safeguard your IP in the metaverse?

Defending Against Infringement Claims with Patent Invalidation

Patent Invalidation or Validation Search

Advantages of Competitive Landscape Analysis

Taming Patent White Space Analysis

How to Patent Your Invention: Patent Landscaping

How Lifi Technology is Transforming Wireless Internet

Artificial Intelligence- The Future of Innovation

How will the metaverse unfold and transform enterprises? Everything you need to know

Will a biosimilar work the same as the original product? Facts you may not know

Which is a Better Approach for Protecting Your Innovation – Patents or Trade Secrets?

How to Adopt Patent Monitoring Services to Track The Patent Filings Of The Competitors

What‌ ‌are‌ ‌the Essential ‌Questions‌ ‌to‌ ‌Ask‌ ‌a‌ ‌Patent‌ ‌Attorney‌ ‌about‌ ‌Legal‌ ‌Expenses‌ ‌and‌ ‌Intellectual‌ ‌Property?‌

Why Intellectual Property Audits are Essential for Businesses?

A Perfect Guide To Protecting Your Neural Networks and Machine Learning Inventions

Guide To Patenting Your Product- How To Conduct A Patentability Search

Hiring a Patent Licensing Professional is Extra Beneficial for your Invention. How?

Challenges which are Posing a Threat to Inventors in Intellectual Property

A Comprehensive Guide On Patent Analytics

Importance, Purpose, Processes and Methods of Patent Claim Charts and Construction

Patent Prior Art Search and 4 Quick Ways to do it

Does Your Organization Have an Intellectual Property Vision?

The Complete Guide to Patent Licensing

Importance of Patents in the Pharmaceutical Industry

Patents Guide and the Patent Process Explained in Simple Terms

5 Tips on How to Patent Your Research

How to Get a Patent & How much will it cost to get a patent?: Everything You Need to Know

Patent Due Diligence — Have You Covered All Your Bases?

How do startups influence the industrial market and why you should keep a track of it?

Patent Strategy: Boosting New Business Opportunities

Supporting Entrepreneurship And Innovation Through Tech-enabled Lawyers of the Future

Integrating Traditional IP Rights and Open Access Initiatives

Breaking the common confusions among Patent Agents and Patent Attorneys

Is your Patent Prosecution Support as effective as it could be?

How to Find Your Business’s White Space Opportunities

A Framework to Extract ROI from Your Patent Portfolio

How Competitive Landscape Analysis can Lead to an Effective R&D Strategy?

Why Vaccine patents are a contentious issue?

Electric Cars – leading our way to a better future

6g Technology VS 5g A Perfect time to lock Your Patent

The dawn of Artificial intelligence and Intellectual Property System

Automotive Cars: A Self driving Future

HR Analytics

Coronavirus Treatment : Prospective Vaccines / Drugs

ABC: All About Covid-19

The New Normal

The New 5G Technology Wave

The World of IoT Sensors

Unleash the Power of your Diverse Portfolio and Size Up Revenues